Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Menotrophin** is a urine-derived human menopausal gonadotropin preparation used to stimulate follicular development and ovulation in infertility treatment, including controlled ovarian stimulation for assisted reproductive technology. It contains follicle-stimulating hormone and luteinizing hormone bioactivity obtained from the urine of postmenopausal women. By activating follicle-stimulating hormone receptors and luteinizing hormone/choriogonadotropin receptors in the ovary, it promotes follicular growth, steroidogenesis, oocyte maturation, and ovulation. Commercial preparations include highly purified injectable products such as Menopur. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22c8db95-c3db-1770-8086-31356fbabe35))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on menotrophin.